Recombinant vaccine against bluetongue virus

Details for Australian Patent Application No. 2007293474 (hide)

Owner The Regents of the University of California Merial Limited

Inventors Yao, Jiansheng; Audonnet, Jean Christophe Francis; Karaca, Kemal; MacLachlan, Nigel James

Agent FB Rice

Pub. Number AU-B-2007293474

PCT Pub. Number WO2008/030282

Priority 11/444,698 01.06.06 US

Filing date 30 May 2007

Wipo publication date 13 March 2008

Acceptance publication date 19 July 2012

International Classifications

C12N 15/863 Mutation or genetic engineering - Poxviral vectors, e.g. vaccinia virus

A61K 39/42 Medicinal preparations containing antigens or antibodies - viral

C07K 14/14 Peptides having more than 20 amino acids

G01N 33/569 Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2008/030282 Priority application(s): WO2008/030282

19 July 2012 Application Accepted

  Published as AU-B-2007293474

1 November 2012 Opposition Lodged

  Pfizer Inc. has lodged an opposition against The Regents of the University of California; Merial Limited.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007293475-Methods of diagnosing and treating complications of pregnancy

2007293468-Low temperature method of making a zinc oxide coated article